
New advances in the explanation of the most common chronic liver disease
The mechanisms that cause the world’s most common chronic liver disease — Metabolic dysfunction-associated steatotic liver disease (MASLD) — to develop and progress are not still fully understood. Now, a study by the IBUB and University of Barcelona has identified a new factor involved in the development of the disease: the protein ENT1, which allows








